Nottingham spinout Locate Therapeutics is developing a polymer-based material that ensures stem cells and other therapies can be injected with precision.
Locate Therapeutics, a drug and stem cell delivery spinout from University of Nottingham, has received £2m ($2.7m) in a round featuring the UK government-backed Midlands Engine Investment Fund (MEIF).
MEIF contributed $532,000 to the deal through its Proof of Concept (POC) and Early Stage Fund, which is managed by Mercia Fund Managers, a subsidiary of investment firm Mercia Technologies.
Locate Therapeutics is developing a polymer-based material called Taos that allows medicines to be injected into the body with greater precision…
